Days ago, the SEC obtained partial final consent judgments against three individuals charged with trading on material non-public information in Portola Pharmaceuticals securities. In its complaint, the SEC contends that one of the defendants, a vice-president at Alexion Pharmaceuticals Inc., knowingly or recklessly tipped non-public, confidential information to a close friend regarding an expected May...Read More